|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.99 EUR | +1.02% |
|
-1.00% | -6.60% |
| 2023 | Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | Bio-Gate AG Signs LOI with North American Medical Device Manufacturer for Trauma Implants | CI |
Bio Gate AG announced earnings results for 2013. For the year, the company's net loss narrowed to EUR 1.5 million from a loss of EUR 2.2 million in 2012. The loss before interest, tax, depreciation and amortization (LBITDA) shrank to EUR 1.1 million from EUR 1.7 million.
Revenue rose by nearly 10% to EUR 2.5 million from EUR 2.3 million as the company managed to cut costs at key divisions.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.60% | 9.78M | |
| -3.72% | 184B | |
| -2.60% | 107B | |
| -3.79% | 67.78B | |
| +2.66% | 50.66B | |
| +16.39% | 47.64B | |
| +4.60% | 41.12B | |
| +1.38% | 26.3B | |
| +1.52% | 26.04B | |
| -1.17% | 24.71B |
BIO-GATE AG 
